MorphoSys Expands Oncology Footprint with Constellation and Royalty Pharma
By Neha Madhwani & Michelle Liu
Pharma Deals Review: Vol 2021 Issue 6 (Table of Contents)
Published: 29 Jun-2021
DOI: 10.3833/pdr.v2021.i6.2618 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In its largest M&A deal to date, MorphoSys has agreed to acquire Constellation Pharmaceuticals to expand its oncology offerings...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS